Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
Fermín Sánchez‐Guijo, Mariano García‐Arranz, Miriam López-Parra, et al.
EClinicalMedicine (2020) Vol. 25, pp. 100454-100454
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
Seyed Mohammad Reza Hashemian, Rasoul Aliannejad, Morteza Zarrabi, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 179
Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19
Loubna Mazini, Mohamed Ezzoubi, Gabriel Malka
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 174
Potential therapeutic options for COVID-19: an update on current evidence
Zahra Niknam, Ameneh Jafari, Ali Golchin, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 138
Adipose-Derived Stem Cells Secretome and Its Potential Application in “Stem Cell-Free Therapy”
Anna Trzyna, Agnieszka Banaś-Ząbczyk
Biomolecules (2021) Vol. 11, Iss. 6, pp. 878-878
Open Access | Times Cited: 134
Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial
Xiaowei Xu, Wanli Jiang, Lijun Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 111
An Update on Adipose‐Derived Stem Cells for Regenerative Medicine: Where Challenge Meets Opportunity
Yi Qin, Gaoran Ge, Peng Yang, et al.
Advanced Science (2023) Vol. 10, Iss. 20
Open Access | Times Cited: 93
Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation
Siyu Wang, Tao Yang, Tiantian Li, et al.
Chinese Medical Journal (2025)
Open Access | Times Cited: 1
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
Zhongwen Li, Shuaishuai Niu, Baojie Guo, et al.
Cell Proliferation (2020) Vol. 53, Iss. 12
Open Access | Times Cited: 95
Mesenchymal stem cell therapy for severe COVID-19
Lei Shi, Lifeng Wang, Ruonan Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 86
Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility
Ali Golchin
Stem Cell Reviews and Reports (2020) Vol. 17, Iss. 1, pp. 56-62
Open Access | Times Cited: 70
Mesenchymal stem cell treatment for COVID-19
Ruonan Xu, Zhiqian Feng, Fu‐Sheng Wang
EBioMedicine (2022) Vol. 77, pp. 103920-103920
Open Access | Times Cited: 56
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
Najmeh Kaffash Farkhad, Alireza Sedaghat, Hamidreza Reihani, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 46
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
Cármen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Cláudio Luciano Franck, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
SARS-CoV-2 Infection and Lung Regeneration
Fuxiaonan Zhao, Qingwen Ma, Qing Yue, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 2
Open Access | Times Cited: 42
Immune responses in mildly versus critically ill COVID-19 patients
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39
Current Strategies and Therapeutic Applications of Mesenchymal Stem Cell-Based Drug Delivery
Yasunari Matsuzaka, Ryu Yashiro
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 707-707
Open Access | Times Cited: 10
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
Sara Al‐Khawaga, Essam M. Abdelalim
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 67
Stem cell therapy for COVID‐19: Possibilities and challenges
Mahmood S. Choudhery, David T. Harris
Cell Biology International (2020) Vol. 44, Iss. 11, pp. 2182-2191
Open Access | Times Cited: 57
Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis
Iago Carvalho Schultz, Ana Paula Santin Bertoni, Márcia Rosângela Wink
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 2, pp. 341-356
Open Access | Times Cited: 53
Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
Michele Carbone, John A. Lednicky, Shu–Yuan Xiao, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 4, pp. 546-571
Open Access | Times Cited: 48
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy
Cristina Ferreras, B. Pascual-Miguel, Carmen Mestre-Durán, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 48
Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment
Arefeh Basiri, Fatemeh Mansouri, Arezo Azari, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 1, pp. 193-213
Open Access | Times Cited: 45
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 33
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment
Hamid Reza Aghayan, Fatemeh Salimian, Atefeh Abedini, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Harnessing three-dimensional (3D) cell culture models for pulmonary infections: State of the art and future directions
Disha D. Shah, Neha R. Raghani, Mehul R. Chorawala, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 11, pp. 2861-2880
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top